Skip to content

About us
CYCLOPS
News
Products
Co-development
Vacancies
Contact

About us
CYCLOPS
News
Products
Co-development
Vacancies
Contact

Cyclops®

Convenient
Reliable
Easy-to-use
Easy-to-carry
Hygienic
Less Cough

About us
CYCLOPS
News
Products
Co-development
Vacancies
Contact

About us
CYCLOPS
News
Products
Co-development
Vacancies
Contact

Drug Delivery to the Lungs (DDL) poster on Epinephrine Cyclops™

Check out our scientific poster for DDL2022 on Epinephrine Cyclops™!

SHARE THIS POST

Recent Posts

Colistin Cyclops® Gains EMA and FDA Orphan Drug Status in Cystic Fibrosis

CYCLOPS® Dry Powder Inhaler Now Available Nationwide in the Netherlands Thanks to Agreement Between Fagron and PureIMS

International Congress of Parkinson’s Disease and Movement Disorders 2024 – poster on Levodopa Cyclops®

Cyclops® in Inhalation Technology magazine!

PureIMS gears up for abbreviated registration of Levodopa Cyclops® against OFF episodes in Parkinson’s disease with the successful completion of a comparative pharmacokinetic study

PureIMS winning the LIFE Science Innovation Award!

PureIMS initiates dose-finding study with Levodopa Cyclops™ dry powder inhaler

PureIMS secures new investment round to develop lead inhalation product and facilitate partnering activities

PureIMS names Frank Lambert to advance commercialization of its Cyclops™ Dry Powder Inhaler (DPI)

PureIMS present at DDL2022

Categories

Categories

Press release (14)
Publication (3)
Scientific publication (6)
Status update (3)

Contact Us

Ceintuurbaan Noord 152
9301 NZ Roden
The Netherlands
T: +31 (0)50 – 2053 325
F: +31 (0)50 – 2053 326
E: info@pureims.com

Social media

Linkedin-in Youtube

Inspiration by Patients

© 2025 pureims